Next Article in Journal
Accumulation, Biotransformation, Histopathology and Paralysis in the Pacific Calico Scallop Argopecten ventricosus by the Paralyzing Toxins of the Dinoflagellate Gymnodinium catenatum
Next Article in Special Issue
Geographic Variability and Anti-Staphylococcal Activity of the Chrysophaentins and Their Synthetic Fragments
Previous Article in Journal
Woodylides A–C, New Cytotoxic Linear Polyketides from the South China Sea Sponge Plakortis simplex
Previous Article in Special Issue
Structural Characterization and Anti-HSV-1 and HSV-2 Activity of Glycolipids from the Marine Algae Osmundaria obtusiloba Isolated from Southeastern Brazilian Coast
Article Menu

Export Article

Open AccessArticle
Mar. Drugs 2012, 10(5), 1037-1043;

Antibacterial Secondary Metabolites from the Cave Sponge Xestospongia sp.

Department of Pharmacognosy, School of Pharmacy, The University of Mississippi, University, MS 38677, USA
Authors to whom correspondence should be addressed.
Received: 5 March 2012 / Revised: 24 April 2012 / Accepted: 1 May 2012 / Published: 7 May 2012
(This article belongs to the Special Issue Marine Anti-infective Agents)
Full-Text   |   PDF [192 KB, uploaded 24 February 2015]   |  


Chemical investigation of the cave sponge Xestospongia sp. resulted in the isolation of three new polyacetylenic long chain compounds along with two known metabolites. The structures of the new metabolites were established by NMR and MS analyses. The antibacterial activity of the new metabolites was also evaluated. View Full-Text
Keywords: Xestospongia; polyacetylenes; antibacterial activity Xestospongia; polyacetylenes; antibacterial activity

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Ankisetty, S.; Slattery, M. Antibacterial Secondary Metabolites from the Cave Sponge Xestospongia sp.. Mar. Drugs 2012, 10, 1037-1043.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top